Gaudium IVF and Women Health Limited
Gaudium IVF and Women Health Limited (GAUDIUMIVF) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
gaudiumivfcentre.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 25 Cr | 30 Cr | 19 Cr |
| Operating expenses (approx.) | 18 Cr | 18 Cr | 17 Cr |
| EBITDA | 7 Cr | 12 Cr | 2 Cr |
| OPM % | 26.7% | 40.1% | 12.5% |
| Other income | 0.10 Cr | 0.18 Cr | 1 Cr |
| Interest | 1 Cr | 1 Cr | 0.38 Cr |
| Depreciation | 0.49 Cr | 0.64 Cr | 0.72 Cr |
| Profit before tax | 5 Cr | 10 Cr | 2 Cr |
| Tax % | 26.9% | 19.8% | 27.5% |
| Net profit | 4 Cr | 8 Cr | 2 Cr |
| EPS (₹) | ₹0.59 | ₹1.34 | ₹0.25 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 104 Cr | Sign in for TTM |
| Operating expenses (approx.) | 67 Cr | Sign in for TTM |
| EBITDA | 38 Cr | Sign in for TTM |
| OPM % | 36.1% | Sign in for TTM |
| Other income | 0.53 Cr | Sign in for TTM |
| Interest | 3 Cr | Sign in for TTM |
| Depreciation | 3 Cr | Sign in for TTM |
| Profit before tax | 32 Cr | Sign in for TTM |
| Tax % | 24.0% | Sign in for TTM |
| Net profit | 24 Cr | Sign in for TTM |
| EPS (₹) | ₹3.92 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 36 Cr |
| Reserves | 116 Cr |
| Borrowings | 23 Cr |
| Other liabilities | 18 Cr |
| Total liabilities | 193 Cr |
| Fixed assets (net) | 7 Cr |
| CWIP | 0 Cr |
| Investments | 5 Cr |
| Inventories | 4 Cr |
| Trade receivables | 53 Cr |
| Cash & bank | 9 Cr |
| Other assets | 115 Cr |
| Total assets | 193 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 7 Cr |
| Cash from investing | -88 Cr |
| Cash from financing | 82 Cr |
| Net cash flow | 2 Cr |
| Free cash flow (OCF − Capex) | 0.53 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 20.3% |
| ROE % | 16.1% |
| Debtor days | 186 |
| Inventory days | 12 |
| Days payable | 43 |
| Cash conversion cycle | 156 |
| Debt / equity | 0.15 |
| Current ratio | 1.90 |
| Net debt / EBITDA | 0.38 |
Compare with peers
Loading peers…